Acromegaly and Gigantism Drugs Market is anticipated to grow at a significant CAGR during the forecast period. The major factor that is expected to boost the market includes the increasing prevalence of the pituitary tumors. Moreover, according to the American Cancer Society, around ten thousand pituitary tumors are diagnosed in America each year. Such a high prevalence rate of this tumor is one of the most important factors, which is augmenting the growth of the market. Furthermore, the rise in prevalence of other chronic disorders such as carney complex and McCune- Albright Syndrome is another factor that is expected to accelerate the growth of the global acromegaly and gigantism drugs market during the forecast period. However, the lack of awareness about the diagnosis and management of the disorder in many developing countries is the major restraining factor of the market.
Acromegaly is a rare hormonal disease that is caused due to excess production of growth hormone in adults. The condition of acromegaly is usually caused by a pituitary tumor. The term acro means extremities and megaly mean enlargement of; thus, acromegaly refers to enlargement of hands and feet. Gigantism is also a hormonal disorder that is caused due to excessive production of the growth hormone during childhood. The disorder is characterized by over bone growth and abnormal height. Acromegaly and gigantism are considered serious illnesses and are life-threatening. Acromegaly and gigantism is a rare disease and according to a journal, Pituitary, the total prevalence of acromegaly ranges from 2.8 to 13.7 cases per 1 lakh people each year. This, in turn, is driving the growth of the global acromegaly and gigantism drugs market.
To Request a Sample of our Report on Acromegaly and Gigantism Drugs Market: https://www.omrglobal.com/request-sample/acromegaly-and-gigantism-drugs-market
Market Coverage
- The market number available for – 2022-2030
- Base year- 2022
- Forecast period- 2023-2030
Segment Covered-
- By Type
- By Application
Regions covered–
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape: Pfizer Inc., Novartis International AG, and Ionis Pharmaceuticals Inc., among others.
A full Report of Acromegaly and Gigantism Drugs Market is Available @ https://www.omrglobal.com/industry-reports/acromegaly-and-gigantism-drugs-market
Acromegaly and Gigantism Drugs Market Report by Segment
By Type
- Somatostatin Analogs
- GH Receptor Antagonists
- Dopamine Agonists
- Recombinant Human IGF-1
By Application
- Hospitals
- Clinics
- Others
Acromegaly and Gigantism Drugs Market Report by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
- Latin America
- Middle East & Africa
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
